The recently approved product contains an ICS-albuterol combination. The 2024 Global Initiative for Asthma (GINA) guidelines recommend as-needed ICS-formoterol as the preferred asthma reliever therapy; however, a GINA alternative recommendation is the use of ICS whenever an as-needed (SAB...
Is an inhaled corticosteroid (ICS)/long-acting beta2 agonist (LABA) combination effective as a relief medication in patients with mild to severe asthma when compared with a short-acting beta2 agonist (SABA)?Karamanis AmberBleacher Heather
Data supporting the use of combination ICS-albuterol reliever therapy in mild asthma are more limited, but there are studies that inform its use in this population. In this review, we compare, using a pros and cons format, the (1) long -term safety and eff i cacy of ICS-formoterol ...